Efficacy and long-term outcomes of radiofrequency ablation in the elderly with hepatocellular carcinoma

Hepatology Research

Volumn 44, Issue 11, 2014, Pages 1095-1101

  Yamazaki, Hajime ^a   Tsuji, Kunihiko ^a   Nagai, Kazumasa ^a   Tomonari, Akiko ^a   Matsui, Takeshi ^a   Kang, Jong Hon ^a   Kodama, Yoshihisa ^a   Sakurai, Yasuo ^a   Maguchi, Hiroyuki ^a  

^a TEINE KEIJINKAI HOSPITAL   (Japan)

Author keywords

Elderly patient; Hepatocellular carcinoma; Long term outcome; Radiofrequency ablation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD PUGH SCORE; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT INFORMATION; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; VERY ELDERLY;

EID: 84914182384     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12233     Document Type: Article

References (16)

1. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264-1273.
2. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 2010; 78: 113-124.
3. Takuma Y, Takabatake H, Morimoto Y etal. Radiofrequency ablation for hepatocellular carcinoma in elderly patients. Nisshoshi 2013; 110: 403-411.
4. Nishikawa H, Osaki Y, Iguchi E etal. Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients. J Gastrointestin Liver Dis 2012; 21: 397-405.
5. Takahashi H, Mizuta T, Kawazoe S etal. Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients. Hepatol Res 2010; 40: 997-1005.
6. Hiraoka A, Michitaka K, Horiike N etal. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients. J Gastroenterol Hepatol 2010; 25: 403-407.
7. Liver Cancer Study Group. General Rules for the Clinical and Pathological Study of Primary Liver Cancer. Engl ed 3. Tokyo: Kanehara, 2010.
8. Tsuji K, Nishimori H, Sakurai Y etal. Efficacy and long-term outcome of laparoscopic microwave coagulation or radiofrequency ablation therapy for surface-type hepatocellular carcinoma. Dig Endosc 2004; 16: 117-121.
9. Shiratori Y, Yoshida H, Omata M. Different clinicopathological features of hepatocellular carcinoma in relation to causative agents. J Gastroenterol 2001; 36: 73-78.
10. Dohmen K, Shigematsu H, Irie K etal. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Hepatogastroenterology 2003; 50: 2022-2027.
11. Kiyosawa K, Tanaka E. Characteristics of hepatocellular carcinoma in Japan. Oncology 2002; 62: 5-7.
12. Kudo M, Izumi N, Kokudo N etal. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version. Dig Dis 2011; 29: 339-364.
13. Oishi K, Itamoto T, Kobayashi T etal. Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. J Gastrointest Surg 2009; 13: 695-701.
14. Mirici-Cappa F, Gramenzi A, Santi V etal. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 2010; 59: 387-396.
15. Shiina S, Tateishi R, Arano T etal. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 2012; 107: 569-577.
16. Tomonari A, Tsuji K, Yamazaki H etal. Feasibility of fused imaging for the evaluation of radiofrequency ablative margin for hepatocellular carcinoma. Hepatol Res 2013; 43: 728-734.